Back

Immune checkpoints as novel mechanism in heart failure and predictors of outcomes

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Young Investigator Award: basic science Pathophysiology HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Wouter Meijers

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Knockdown of phospholamban using antisense oligonucleotides halts disease progression and resolves protein aggregation in mice with advanced phospholamban p.Arg14del cardiomyopathy
Mr T. Eijgenraam (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
DWORF diminishes clustering of phospholamban in a PLN-R14del cardiomyopathy mouse model and extends life span
Ms N. Stege (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Electrophysiological anomalies associated with a noonan syndrome mutation in RAF1 contribute to the development of cardiac arrhythmias
Doctor F. Haghighi (Goettingen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award: basic science
Video

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Chronic kidney disease and heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources